| CG42 |
Dementia (CG42) |
|
-
-
dementia
Fast, easy summary view of NICE guidance on 'dementia'
-
-
-
Dementia: Supporting people with dementia and their carers in health and social care
Summary of guidance
This guideline makes specific recommendations on Alzheimer's disease, dementia with Lewy bodies (DLB), frontotemporal dementia, vascular dementia and mixed dementias, as well as recommendations that apply to all types of dementia. Dementia in Parkinson's disease shares a number of similarities with DLB. Although the evidence base for dementia in Parkinson's disease was not examined specifically in the context of this guideline, the recommendations for DLB may be useful when considering treatments for dementia in Parkinson's disease. NICE has also produced a clinical guideline on Parkinson's disease (available from www.nice.org.uk/CG035).
The dementia guideline incorporates recommendations from NICE's technology appraisal of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease.
Amendment March 2011
The clinical guideline has been amended to incorporate the updated NICE technology appraisal of drugs for Alzheimer's disease, published in March 2011.
The amended version of the full guideline will be available shortly.
NICE has amended and reissued the technology appraisal guidance on donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease.
The review and re-appraisal of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease has resulted in a change in the guidance. Specifically:
- donepezil, galantamine and rivastigmine are now recommended as options for managing mild as well as moderate Alzheimer’s disease, and
- memantine is now recommended as an option for managing moderate Alzheimer’s disease for people who cannot take AChE inhibitors, and as an option for managing severe Alzheimer’s disease.
-
Other information
NICE Pathways
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: dementia
How this guidance was produced
Background information
This page was last updated: 30 January 2012
-
Guideline formats
-
Implementation tools and resources
- Clinical audit tool
- Costing report
- Costing template
- Slide set
- Online learning resource
- Dementia: implementation advice
- Dementia: audit criteria
- Memory assessment service commissioning guide
- End of life care for people with dementia commissioning guide
See this guidance in practice
Patient
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
NICE Guideline
The published NICE clinical guideline, contains the recommendations for health professionals and NHS bodies.
Full Guideline
The published full clinical guideline for specialists with background, evidence, recommendations and methods used.
